Home > > Europe And Global Light Therapy Market- Size, Share, Growth Rate, and Forecast
The Europe Light Therapy market was valued at $408.8 Million in 2023, and is projected to reach $538.4 Million by 2030 growing at a CAGR of 4.06% from 2024 to 2030. Psoriasis segment is expected to be the highest contributor to this market, with $91.8 Million in 2023, and is anticipated to reach $119.4 by 2030, registering a CAGR of 3.87%. Acne Vulgaris segment is anticipated to reach $110.0 Million by 2030 with the highest CAGR of 4.28%. Psoriasis and Acne Vulgaris segments collectively expected to account for about 42.6% share of the Europe Light Therapy market in 2023, with the former constituting around 22.5% share. Acne Vulgaris and SAD segments are expected to witness significant growth rates at a CAGR of 4.28% and 4.19% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 31.2% in the overall Europe Light Therapy market in 2023, and is anticipated to reach 31.6% by 2030. Application Psoriasis Vitiligo Eczema Acne Vulgaris Winter Blues Sleeping Disorders SAD Other Applications End user Homecare settings Dermatology clinics Other End users Product Light Box Floor and Desk Lamps Light Visor HDST Dawn Simulator Light Therapy Bulbs Other Products BY REGION North America U.s. Canada Mexico Europe Germany France UK Italy Spain Rest of Europe Asia China India Japan South Korea Australia Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA